Head for the Cure 5K

Head for the Cure 5K
Event Information:
Sunday, August 29, 2021 8:00 AM
Corporate Woods

Overland Park, KS

The 19th annual Head for the Cure 5K returns to the traditional format at 8 a.m. on August 29th at Corporate Woods!

Register at www.HeadfortheCure.org/metro-kc. Registration fee: $32 until 8/23; then $40.
Head for the Cure 5K is a family-oriented activity. Those who register are guaranteed an event T-shirt and finisher medal.

The mission of Head for the Cure is to build awareness, raise funds, and inspire hope for the community of brain cancer patients, survivors, their families, friends, caregivers, and other supporters while celebrating their courage, spirit, and energy.
The Head for the Cure Foundation has raised more than $17 million for brain cancer research since 2003 when the first HFTC 5K was organized in suburban Kansas City. Despite the many challenges of 2020, primarily the result of the pandemic, the Foundation raised nearly $2.2 million in ‘20 and locally granted $160,000 to KU Cancer Center; $20,000 to the Children's Brain Tumor Project and $5,000 to Solace House. 

Head for the Cure raises funds to support brain tumor research nationally at the Brain Tumor Trials Collaborative (BTTC), and locally at the University of Kansas Cancer Center  and Solace House. The BTTC is a network of 33 medical centers (led by the National Institutes of Health in Washington, D.C.) with the expertise and desire to participate in state-of-the-art clinical trials investigating new treatments for malignant brain tumors.
The 5K event recognizes those who have been impacted by a brain tumor diagnosis and honors nominated survivors and caregivers with the "Keeping the Faith" and “Legacy of Love" activities.
More than any other cancer, brain tumors can have lasting and life-altering physical, cognitive, and psychological impacts on a patient’s life. More than 120 different types of tumors exist, but only five FDA-approved drugs and one approved device are available to treat all brain tumors. The average survival rate of a glioblastoma patient (the most deadly type of tumor) is 14-16 months.